Shanghai Haishun New Pharmaceutical Packaging Co Ltd (300501) - Net Assets
Based on the latest financial reports, Shanghai Haishun New Pharmaceutical Packaging Co Ltd (300501) has net assets worth CN¥1.72 Billion CNY (≈ $251.40 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥2.91 Billion ≈ $425.37 Million USD) and total liabilities (CN¥1.19 Billion ≈ $173.98 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check 300501 financial resilience to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥1.72 Billion |
| % of Total Assets | 59.1% |
| Annual Growth Rate | 20.19% |
| 5-Year Change | 8.36% |
| 10-Year Change | 189.02% |
| Growth Volatility | 33.19 |
Shanghai Haishun New Pharmaceutical Packaging Co Ltd - Net Assets Trend (2011–2025)
This chart illustrates how Shanghai Haishun New Pharmaceutical Packaging Co Ltd's net assets have evolved over time, based on quarterly financial data. Also explore 300501 total asset value for the complete picture of this company's asset base.
Annual Net Assets for Shanghai Haishun New Pharmaceutical Packaging Co Ltd (2011–2025)
The table below shows the annual net assets of Shanghai Haishun New Pharmaceutical Packaging Co Ltd from 2011 to 2025. For live valuation and market cap data, see Shanghai Haishun New Pharmaceutical Pack stock valuation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥1.72 Billion ≈ $251.40 Million |
-6.01% |
| 2024-12-31 | CN¥1.83 Billion ≈ $267.48 Million |
-4.94% |
| 2023-12-31 | CN¥1.92 Billion ≈ $281.38 Million |
+14.49% |
| 2022-12-31 | CN¥1.68 Billion ≈ $245.77 Million |
+5.93% |
| 2021-12-31 | CN¥1.59 Billion ≈ $232.01 Million |
+80.91% |
| 2020-12-31 | CN¥876.40 Million ≈ $128.25 Million |
+14.96% |
| 2019-12-31 | CN¥762.37 Million ≈ $111.56 Million |
+6.65% |
| 2018-12-31 | CN¥714.84 Million ≈ $104.60 Million |
+12.81% |
| 2017-12-31 | CN¥633.69 Million ≈ $92.73 Million |
+6.61% |
| 2016-12-31 | CN¥594.42 Million ≈ $86.98 Million |
+119.41% |
| 2015-12-31 | CN¥270.92 Million ≈ $39.64 Million |
+16.71% |
| 2014-12-31 | CN¥232.14 Million ≈ $33.97 Million |
+18.53% |
| 2013-12-31 | CN¥195.85 Million ≈ $28.66 Million |
+18.79% |
| 2012-12-31 | CN¥164.87 Million ≈ $24.13 Million |
+26.04% |
| 2011-12-31 | CN¥130.81 Million ≈ $19.14 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Shanghai Haishun New Pharmaceutical Packaging Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 2188.8% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥464.93 Million | 29.82% |
| Common Stock | CN¥193.54 Million | 12.41% |
| Other Comprehensive Income | CN¥284.42 Million | 18.24% |
| Other Components | CN¥616.16 Million | 39.52% |
| Total Equity | CN¥1.56 Billion | 100.00% |
Shanghai Haishun New Pharmaceutical Packaging Co Ltd Competitors by Market Cap
The table below lists competitors of Shanghai Haishun New Pharmaceutical Packaging Co Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
HeidelbergCement India Limited
NSE:HEIDELBERG
|
$389.25 Million |
|
Blend Labs Inc
NYSE:BLND
|
$389.30 Million |
|
Hunan Investment Group Co Ltd
SHE:000548
|
$389.36 Million |
|
Gravity Co. Ltd
F:GD8A
|
$389.69 Million |
|
Contango ORE Inc
NYSE MKT:CTGO
|
$389.08 Million |
|
ITAFOS INC. ON
F:82E
|
$389.03 Million |
|
MGP Ingredients Inc
NASDAQ:MGPI
|
$389.02 Million |
|
Shenzhen New Land Co Ltd
SHE:300778
|
$388.91 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Shanghai Haishun New Pharmaceutical Packaging Co Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 1,740,925,704 to 1,559,047,880, a change of -181,877,824 (-10.4%).
- Net loss of 23,266,931 reduced equity.
- Dividend payments of 87,444,449 reduced retained earnings.
- Share repurchases of 80,537,970 reduced equity.
- Other comprehensive income increased equity by 8,112,681.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥-23.27 Million | -1.49% |
| Dividends Paid | CN¥87.44 Million | -5.61% |
| Share Repurchases | CN¥80.54 Million | -5.17% |
| Other Comprehensive Income | CN¥8.11 Million | +0.52% |
| Other Changes | CN¥1.26 Million | +0.08% |
| Total Change | CN¥- | -10.45% |
Book Value vs Market Value Analysis
This analysis compares Shanghai Haishun New Pharmaceutical Packaging Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.58x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 11.56x to 1.58x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2011-12-31 | CN¥1.19 | CN¥13.74 | x |
| 2012-12-31 | CN¥1.45 | CN¥13.74 | x |
| 2013-12-31 | CN¥1.71 | CN¥13.74 | x |
| 2014-12-31 | CN¥2.04 | CN¥13.74 | x |
| 2015-12-31 | CN¥2.38 | CN¥13.74 | x |
| 2016-12-31 | CN¥3.94 | CN¥13.74 | x |
| 2017-12-31 | CN¥4.03 | CN¥13.74 | x |
| 2018-12-31 | CN¥4.29 | CN¥13.74 | x |
| 2019-12-31 | CN¥4.45 | CN¥13.74 | x |
| 2020-12-31 | CN¥5.24 | CN¥13.74 | x |
| 2021-12-31 | CN¥9.23 | CN¥13.74 | x |
| 2022-12-31 | CN¥8.26 | CN¥13.74 | x |
| 2023-12-31 | CN¥9.43 | CN¥13.74 | x |
| 2024-12-31 | CN¥9.10 | CN¥13.74 | x |
| 2025-12-31 | CN¥8.71 | CN¥13.74 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Shanghai Haishun New Pharmaceutical Packaging Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -1.49%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -2.11%
- • Asset Turnover: 0.38x
- • Equity Multiplier: 1.86x
- Recent ROE (-1.49%) is below the historical average (11.97%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2011 | 15.13% | 13.28% | 0.80x | 1.43x | CN¥6.71 Million |
| 2012 | 20.66% | 16.20% | 0.95x | 1.34x | CN¥17.57 Million |
| 2013 | 22.88% | 16.03% | 1.08x | 1.32x | CN¥25.03 Million |
| 2014 | 23.52% | 18.71% | 1.01x | 1.25x | CN¥31.17 Million |
| 2015 | 21.82% | 19.99% | 0.87x | 1.26x | CN¥31.84 Million |
| 2016 | 11.28% | 21.44% | 0.44x | 1.19x | CN¥7.35 Million |
| 2017 | 10.75% | 17.52% | 0.53x | 1.16x | CN¥4.62 Million |
| 2018 | 10.26% | 13.05% | 0.54x | 1.46x | CN¥1.67 Million |
| 2019 | 9.65% | 10.78% | 0.50x | 1.78x | CN¥-2.40 Million |
| 2020 | 12.78% | 14.42% | 0.51x | 1.75x | CN¥22.38 Million |
| 2021 | 6.93% | 12.21% | 0.38x | 1.50x | CN¥-46.35 Million |
| 2022 | 6.42% | 10.12% | 0.44x | 1.44x | CN¥-57.20 Million |
| 2023 | 4.67% | 8.37% | 0.34x | 1.63x | CN¥-97.66 Million |
| 2024 | 4.28% | 6.53% | 0.40x | 1.66x | CN¥-99.50 Million |
| 2025 | -1.49% | -2.11% | 0.38x | 1.86x | CN¥-179.17 Million |
Industry Comparison
This section compares Shanghai Haishun New Pharmaceutical Packaging Co Ltd's net assets metrics with peer companies in the Packaging & Containers industry.
Industry Context
- Industry: Packaging & Containers
- Average net assets among peers: $1,715,624,811
- Average return on equity (ROE) among peers: 9.62%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Shanghai Haishun New Pharmaceutical Packaging Co Ltd (300501) | CN¥1.72 Billion | 15.13% | 0.69x | $389.13 Million |
| Zhuhai Zhongfu Enterprise Co Ltd (000659) | $250.28 Million | 0.00% | 0.93x | $758.20 Million |
| Huangshan Novel Co Ltd (002014) | $698.53 Million | 14.41% | 0.40x | $1.00 Billion |
| Shenzhen Jinjia Color Printing Group Co Ltd (002191) | $409.16 Million | 34.54% | 2.21x | $805.15 Million |
| Xiamen Hexing Packaging Printing Co Ltd (002228) | $2.77 Billion | 6.86% | 1.33x | $692.47 Million |
| Shenzhen Beauty Star Co Ltd (002243) | $590.09 Million | 16.39% | 0.36x | $1.51 Billion |
| Zhejiang Great Southeast Co Ltd (002263) | $942.33 Million | 5.01% | 0.84x | $1.11 Billion |
| Shenzhen MYS Environmental Protection & Technology Co Ltd (002303) | $4.90 Billion | 3.96% | 0.48x | $761.87 Million |
| Shandong Lipeng Co Ltd (002374) | $2.01 Billion | 6.03% | 0.89x | $511.34 Million |
| Zhejiang Zhongcheng Packing Material Co Ltd (002522) | $2.31 Billion | 4.51% | 0.59x | $841.65 Million |
| Shanghai Luxin Packing Materials Science&Technology Co Ltd (002565) | $2.28 Billion | 4.45% | 0.59x | $2.95 Billion |
About Shanghai Haishun New Pharmaceutical Packaging Co Ltd
HySum Flexibles Global, Inc. engages in the manufacture, sale, and export of pharmaceutical packaging products in China and internationally. The company offers pharmaceuticals packaging products, including cold-form, tropical foil, PVC/Aclar sheets, PTP lidding, hipack child-resistant packaging, hipack AL/PE strip packs, hipack complex laminated flexible films, lamination foil and pouch, composit… Read more